Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 8/20 | 0.97 |
| ▸ | MAPT | P10636 | 4/20 | 0.97 |
| ▸ | MEN1 | O00255 | 4/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.97 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.97 |
| ▸ | HTT | P42858 | 2/20 | 0.97 |
| ▸ | HPGD | P15428 | 2/20 | 0.97 |
| ▸ | RECQL | P46063 | 2/20 | 0.97 |
| ▸ | BLM | P54132 | 2/20 | 0.97 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.97 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.97 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.97 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.97 |
| ▸ | LMNA | P02545 | 3/20 | 0.68 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.68 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | USP2 | O75604 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluorescein SCHEMBL8144835 | 1.00 | FTO (0.97) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL6691088 | 0.99 | FTO (0.94) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL3645090 | 0.98 | FTO (1.00) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL29388667 | 0.98 | FTO (1.00) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL29371199 | 0.98 | FTO (1.00) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL16533 | 0.98 | FTO (1.00) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL30272223 | 0.98 | FTO (1.00) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL4167675 | 0.97 | FTO (0.92) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL17867543 | 0.97 | FTO (0.97) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL21194999 | 0.97 | FTO (0.97) | FTOMAPTMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1073 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115825018-A | Fluorescent biological polysaccharide for nano pesticide in-situ fluorescence detection and detection method thereof | 中山大学 | 2023-03-21 | — | — | CN | claimed |
| US-20210275693-A1 | MODIFIED WOUND DRESSINGS | CONVATEC TECHNOLOGIES INC. | 2021-09-09 | — | — | US | claimed |
| CN-112055595-A | Methods of use of CAR T cells | 恩多塞特公司 | 2020-12-08 | — | — | CN | claimed |
| US-10781442-B2 | High-speed in vitro screening method | EPSILON MOLECULAR ENGINEERING INC. (JP) | 2020-09-22 | — | — | US | claimed |
| US-20190307904-A1 | MODIFIED WOUND DRESSINGS | CONVATEC TECHNOLOGIES INC (US) | 2019-10-10 | — | — | US | claimed |
| US-20190085322-A1 | HIGH-SPEED IN VITRO SCREENING METHOD | EPSILON MOLECULAR ENGINEERING INC. (JP) | 2019-03-21 | — | — | US | claimed |
| EP-3436012-A1 | MODIFIED WOUND DRESSINGS | ConvaTec Technologies Inc. (US) | 2019-02-06 | — | — | EP | claimed |
| CN-109219436-A | modified wound dressing | 康沃特克科技公司 | 2019-01-15 | — | — | CN | claimed |
| CN-107421863-A | It is a kind of to combine the PM that monodisperse aerosol occurs1Cutting head Performance Test System | 北京航空航天大学 | 2017-12-01 | — | — | CN | claimed |
| WO-2017173026-A1 | MODIFIED WOUND DRESSINGS | CONVATEC TECHNOLOGIES INC. (US) | 2017-10-05 | — | — | WO | claimed |
| EP-0708767-A1 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR CARBAZOLE AND DIBENZOFURAN DERIVATIVES | ABBOTT LABORATORIES (US) | 1996-05-01 | — | — | EP | claimed |
| EP-0702689-A1 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR 3-PHENYL-1-ADAMANTANEACETIC ACIDS | ABBOTT LABORATORIES (US) | 1996-03-27 | — | — | EP | claimed |
| US-5424414-A | Haptens, tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids | ABBOTT LABORATORIES (US) | 1995-06-13 | — | — | US | claimed |
| WO-1995003296-A1 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR CARBAZOLE AND DIBENZOFURAN DERIVATIVES | ABBOTT LABORATORIES (US) | 1995-02-02 | — | — | WO | claimed |
| WO-1994029329-A1 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR 3-PHENYL-1-ADAMANTANEACETIC ACIDS | ABBOTT LABORATORIES (US) | 1994-12-22 | — | — | WO | claimed |
| WO-1993020074-A1 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR ACRIDINE-9-CARBOXYLIC ACIDS | ABBOTT LABORATORIES (US) | 1993-10-14 | — | — | WO | claimed |
| WO-1993020094-A1 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR QUINOLINE | ABBOTT LABORATORIES (US) | 1993-10-14 | — | — | WO | claimed |
| US-5145790-A | Immunoassay, fluorescein derivative | ABBOTT LABORATORIES (US) | 1992-09-08 | — | — | US | claimed |
| EP-0455058-A2 | Reagents and method for detecting polychlorinated biphenyls | ABBOTT LABORATORIES (US) | 1991-11-06 | — | — | EP | claimed |
| US-4171311-A | Imides of thyroxin and triiodothyronine | International Diagnostics Tech. Inc. (US) | 1979-10-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190307904-A1 | MODIFIED WOUND DRESSINGS | MMP8, CD68, ELANE | FTO 850/4885MAPT 4774/4885MEN1 4751/4885 |
| US-20210275693-A1 | MODIFIED WOUND DRESSINGS | MMP8, CD68, ELANE | FTO 850/4885MAPT 4774/4885MEN1 4751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.